DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Acknowledgments
In the reply, filed on March 12, 2025, Applicant cancelled claims 2-8, 21, and 27-28
Applicant amended claim 26.
Information Disclosure Statement
The information disclosure statement filed June 26, 2024, fails to comply with 37 CFR 1.98(a)(2), which requires a legible copy of each cited foreign patent document; each non-patent literature publication or that portion which caused it to be listed; and all other information or that portion which caused it to be listed. It has been placed in the application file, but the information referred to therein has not been considered:
While a copy of an English translation for CN106075687 has been provided, no copy of CN106075687 itself has been provided
Drawings
The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, “silicon valves” (claim 1, line 14; claim 9, line 16), “sensors” (claim 16, line 2), and “an integrated temperature control mechanism” (claim 17, lines 1-2) must be shown or the feature(s) canceled from the claim(s). No new matter should be entered.
Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance.
Specification
The abstract of the disclosure is objected to because:
In line 1, “the use” should be changed to “a use”
In lines 1-2, “the administration” should be changed to “administration”
In line 2, “biologies” should be changed to “biologics”
In line 2, “the rest” should be changed to “a rest”
In line 2, “the lungs” should be changed to “the lung tissue”
In line 3, “the novel airway device” should be changed to “the airway device”
In line 3, “the performance” should be changed to “performance”
In line 4, “The advantage” should be changed to “An advantage”
In line 5, “the airway” should be changed to “an airway”
A corrected abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text. See MPEP § 608.01(b).
Claim Objections
Claims 1, 9-14, 16-20, 22, 25, and 30 are objected to because of the following informalities:
In regards to claim 1, line 2, “elongated body” should be changed to “an elongated body”.
In regards to claim 1, line 4, “the outside” should be changed to “an outside”.
In regards to claim 1, line 6, “the trachea” should be changed to “a trachea”.
In regards to claim 1, line 6, “a subject” should be changed to “the subject”.
In regards to claim 1, line 10, “the patient” should be changed to “the subject”.
In regards to claim 1, line 10, “the proximal end” should be changed to “a proximal end”.
In regards to claim 1, line 12, “the patient” should be changed to “the subject”.
In regards to claim 1, line 14, “The valves” should be changed to “the valves”.
In regards to claim 1, line 15, “the cap provides seal” should be changed to “the caps provide seals”.
In regards to claim 1, lines 15-16, “mechanical ventilation.” should be changed to “mechanical ventilation;”.
In regards to claim 1, line 17, “selective delivery device” should be changed to “a selective delivery device”.
In regards to claim 1, line 20, “the lobe” should be changed to “a lobe”.
In regards to claim 1, line 20, “the rest” should be changed to “a rest”.
In regards to claim 1, line 20, “the lungs” should be changed to “lungs”.
In regards to claim 1, line 21, “position” should be changed to “positioned”.
In regards to claim 1, line 21, “the lung” should be changed to “the lungs”.
In regards to claim 1, line 22, “lobar tube forms” should be changed to “the lobar tube form”.
In regards to claim 1, line 26, “the administration of therapies” should be changed to “the delivery of the therapies”.
In regards to claim 1, line 27, “the other lung lobes” should be changed to “other lung lobes”.
In regards to claim 9, line 5, “the trachea” should be changed to “a trachea”.
In regards to claim 9, line 5, “a subject” should be changed to “the subject”.
In regards to claim 9, line 11, “the patient” should be changed to “the subject”.
In regards to claim 9, line 11, “the proximal end” should be changed to “a proximal end”.
In regards to claim 9, line 14, “the patient” should be changed to “the subject”.
In regards to claim 9, line 17, “the cap configured to provide a seal” should be changed to “the caps configured to provide seals”.
In regards to claim 9, line 19, “selective delivery device” should be changed to “a selective delivery device”.
In regards to claim 9, line 21, “the secondary lumen of the endotracheal tube” should be changed to “the secondary lumen of the expandable sheath of the endotracheal tube”.
In regards to claim 9, line 22, “the lobe” should be changed to “a lobe”.
In regards to claim 9, line 22, “the rest” should be changed to “a rest”.
In regards to claim 9, lines 22-23, “the lungs” should be changed to “lungs”.
In regards to claim 9, line 23, “position” should be changed to “positioned”.
In regards to claim 9, lines 23-24, “the lung” should be changed to “the lungs”.
In regards to claim 9, line 26, “lobar tube” should be changed to “the lobar tube”.
In regards to claim 9, line 27, “the lobar tube lumen configure” should be changed to “the lobar lumen configured”.
In regards to claim 9, line 30, “administration of therapies” should be changed to “the delivery of the therapies”.
In regards to claim 10, lines 3-4, “the procedure” should be changed to “a procedure”.
In regards to claim 11, line 2, “the sheath lumen” should be changed to “the expandable secondary lumen”.
In regards to claim 11, line 3, “airway a foreign body” should be changed to “an airway foreign body”.
In regards to claim 12, line 2, “lung” should be changed to “lungs”.
In regards to claim 12, line 2, “lung segments comprising” should be changed to “lung segments, the therapeutic delivery system comprising”.
In regards to claim 13, line 2, “aerosol, or gas” should be changed to “an aerosol, or a gas”.
In regards to claim 14, line 2, “lobar tube” should be changed to “the lobar tube”.
In regards to claim 14, line 3, “a double or triple-lumen tube” should be changed to “a double-lumen tube or a triple-lumen tube”.
In regards to claim 14, line 3, “the number” should be changed to “a number”.
In regards to claim 14, line 4, “the expandible sheath” should be changed to “the expandable sheath”.
In regards to claim 16, line 4, “the monitored parameters” should be changed to “the measured parameters”.
In regards to claim 17, line 3, “the temperature of the therapeutic agents” should be changed to “a temperature of therapeutic agents”.
In regards to claim 18, line 2, “comprising” should be changed to “the method comprising”.
In regards to claim 19, lines 1-2, “the left or right main bronchi, lobar bronchi, or segmental bronchi” should be changed to “a left main bronchi or a right main bronchi, a lobar bronchi, or a segmental bronchi”.
In regards to claim 20, lines 1-2, “the lobar tube cuff” should be changed to “the lobar cuff”.
In regards to claim 22, line 1, “the drugs” should be changed to “drugs”.
In regards to claim 22, lines 1-2, “a liquid solution comprising” should be changed to “a liquid solution, the method comprising”.
In regards to claim 22, line 4, “the volume” should be changed to “a volume”.
In regards to claim 25, lines 2-3, “the remaining lung zones” should be changed to “remaining lung zones”.
In regards to claim 30, line 4, “the non-treated lung” should be changed to “a non-treated lung”.
Appropriate correction is required.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1, 9-20, 22-26, and 29-30 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
In regards to claim 1, line 4 recites the limitation "the tube". There is insufficient antecedent basis for this limitation in the claim.
In regards to claim 1, line 7 recites the limitation "the tracheal portion". There is insufficient antecedent basis for this limitation in the claim.
In regards to claim 1, lines 8-9 recite the limitation "the endotracheal tube". There is insufficient antecedent basis for this limitation in the claim.
In regards to claim 1, line 21 recites “one lobe”. Claim 1, line 20 previously recites “the lobe”. It is unclear whether the two recitations are the same or different.
In regards to claim 1, line 22 recites “an assembly”. Claim 1, line 1 previously recites “A respiratory apparatus assembly”. It is unclear whether the two recitations are the same or different.
In regards to claim 1, line 22 recites “isolated lumens”. Claim 1, lines 2-3 previously recite “a primary lumen” and “an expandable secondary channel or lumen” and lines 17-18 previously recite “a lobar lumen”. It is unclear whether “isolated lumens” are the same or different from “a primary lumen”, “an expandable secondary channel or lumen”, and “a lobar lumen”.
In regards to claim 1, line 23 recites “a lobar tube lumen”. Claim 1, lines 17-18 previously recite “a lobar lumen”. It is unclear whether the two recitations are the same or different.
In regards to claim 1, line 24 recites “an endotracheal tube lumen”. Claim 1, lines 2-3 previously recite “a primary lumen” and “an expandable secondary channel or lumen”. It is unclear whether “an endotracheal tube lumen” is the same or different from “a primary lumen” or “an expandable secondary channel or lumen”.
In regards to claim 1, line 26 recites “the assembly”. Claim 1, line 1 previously recites “A respiratory apparatus assembly” and line 22 previously recites “the assembly”. It is unclear which assembly is referred to by the term “the assembly” in claim 1, line 26.
In regards to claim 9, line 6 recites the limitation "the tracheal portion". There is insufficient antecedent basis for this limitation in the claim. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 6 recites the limitation "the tube". There is insufficient antecedent basis for this limitation in the claim. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, lines 2-8 recite: an endotracheal tube comprising:… an expandable sheath external to the endotracheal tube. “an endotracheal tube comprising:… an expandable sheath” means the expandable sheath is part of the endotracheal tube. And “an expandable sheath external to the endotracheal tube” means the expandable sheath is separate from the endotracheal tube. It is unclear how the expandable sheath can be both part of the endotracheal tube and separate from the endotracheal tube. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, lines 2-10 recite: an endotracheal tube comprising:… an expandable sheath external to the endotracheal tube forming an expandable secondary lumen, the secondary lumen is positioned outside the endotracheal tube. “an endotracheal tube comprising:… an expandable sheath external to the endotracheal tube forming an expandable secondary lumen” means the secondary lumen is part of the endotracheal tube. And “the secondary lumen is positioned outside the endotracheal tube” means the secondary lumen is separate from the endotracheal tube. It is unclear how the secondary lumen can be both part of the endotracheal tube and separate from the endotracheal tube. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, lines 2-12 recite: an endotracheal tube comprising:… a first connector located external to the patient and on the proximal end of the endotracheal tube. “an endotracheal tube comprising:… a first connector” means the first connector is part of the endotracheal tube. And “a first connector located external to the patient and on the proximal end of the endotracheal tube” means the first connector is separate from the endotracheal tube. It is unclear how the first connector can be both part of the endotracheal tube and separate from the endotracheal tube. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 23 recites “one lobe”. Claim 9, line 22 previously recites “the lobe”. It is unclear whether the two recitations are the same or different. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 26 recites “an assembly”. Claim 9, line 1 previously recites “A respiratory apparatus assembly”. It is unclear whether the two recitations are the same or different. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 27 recites “isolated lumens”. Claim 9, line 3 previously recites “a primary lumen”, lines 8-9 previously recite “an expandable secondary lumen”, and line 20 previously recites “a lobar lumen”. It is unclear whether “isolated lumens” are the same or different from “a primary lumen”, “an expandable secondary lumen”, and “a lobar lumen”. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 28 recites “an endotracheal tube lumen”. Claim 9, line 3 previously recites “a primary lumen” and lines 8-9 previously recite “an expandable secondary lumen”. It is unclear whether “an endotracheal tube lumen” is the same or different from “a primary lumen” or “an expandable secondary lumen”. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 30 recites “the assembly”. Claim 9, line 1 previously recites “A respiratory apparatus assembly” and line 26 previously recites “an assembly”. It is unclear which assembly is referred to by the term “the assembly” in claim 9, line 30. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 9, line 31 recites “one lobe”. Claim 9, line 22 previously recites “the lobe” and line 23 previously recites “one lobe”. It is unclear whether the three recitations are the same or different. Claims 10-20, 22-26, and 29-30 are rejected by virtue of being dependent upon claim 9.
In regards to claim 10, line 1 recites “The assembly”. Claim 10 depends upon claim 9. Claim 9, line 1 previously recites “A respiratory apparatus assembly” and line 26 previously recites “an assembly”. It is unclear which assembly is referred to by the term “The assembly” in claim 10, line 1.
In regards to claim 10, line 2 recites “working channels”. Claim 10 depends upon claim 9. Claim 9, line 3 previously recites “a primary lumen”, lines 8-9 previously recite “an expandable secondary lumen”, and line 20 previously recites “a lobar lumen”. It is unclear whether “working channels” are the same or different from “a primary lumen”, “an expandable secondary lumen”, and “a lobar lumen”.
In regards to claim 10, line 3 recites “instrumentation”. Claim 10 depends upon claim 9. Claim 9, line 17 previously recites “instrumentation”. It is unclear whether the two recitations are the same or different.
In regards to claim 11, line 1 recites “The assembly”. Claim 11 depends upon claim 9. Claim 9, line 1 previously recites “A respiratory apparatus assembly” and line 26 previously recites “an assembly”. It is unclear which assembly is referred to by the term “The assembly” in claim 11, line 1.
In regards to claim 11, line 2 recites “a removable proximal cap”. Claim 11 depends upon claim 9. Claim 9, line 16 previously recites “caps”. It is unclear whether the two recitations are the same or different.
In regards to claim 12, line 2 recites “a device of claim 9”. Claim 9, line 1 recites “A respiratory apparatus assembly”. Thus, it is unclear whether claim 12, line 2 should instead recite “the respiratory apparatus assembly of claim 9”. Claims 13-15 and 18-20 are rejected by virtue of being dependent upon claim 12.
In regards to claim 14, line 2 recites “an assembly”. Claim 14 depends upon claim 12, which depends upon claim 9. Claim 9, line 1 previously recites “A respiratory apparatus assembly” and line 26 previously recites “an assembly”. It is unclear whether the three recitations are the same or different. Claims 18-20 are rejected by virtue of being dependent upon claim 14.
In regards to claim 15, line 2 recites “delivery”. Claim 15 depends upon claim 12, which depends upon claim 9. Claim 9, line 28 previously recites “delivery”. It is unclear whether the two recitations are the same or different.
In regards to claim 15, line 2 recites “two-lung ventilation”. Claim 15 depends upon claim 12, which depends upon claim 9. Claim 9, line 18 previously recites “mechanical ventilation” and line 31 previously recites “simultaneous ventilation”. It is unclear whether “two-lung ventilation” is the same or different from “mechanical ventilation” or “simultaneous ventilation”.
In regards to claim 15, line 2 recites “one-lung ventilation”. Claim 15 depends upon claim 12, which depends upon claim 9. Claim 9, line 18 previously recites “mechanical ventilation” and line 31 previously recites “simultaneous ventilation”. It is unclear whether “one-lung ventilation” is the same or different from “mechanical ventilation” or “simultaneous ventilation”.
In regards to claim 16, line 1 recites “The assembly”. Claim 16 depends upon claim 9. Claim 9, line 1 previously recites “A respiratory apparatus assembly” and line 26 previously recites “an assembly”. It is unclear which assembly is referred to by the term “The assembly” in claim 16, line 1.
In regards to claim 16, line 3 recites the limitation "the isolated lung segment". There is insufficient antecedent basis for this limitation in the claim.
In regards to claim 16, line 3 recites the limitation "the therapy". First, there is insufficient antecedent basis for this limitation in the claim. Second, claim 16 depends upon claim 9. Claim 9, line 28 previously recites “therapies”. It is unclear whether the two recitations are the same or different.
In regards to claim 16, line 4 recites the limitation "therapy". Claim 16, line 3 previously recites “the therapy”. Claim 16 depends upon claim 9. Claim 9, line 28 previously recites “therapies”. It is unclear whether the three recitations are the same or different.
In regards to claim 17, line 1 recites “The assembly”. Claim 17 depends upon claim 9. Claim 9, line 1 previously recites “A respiratory apparatus assembly” and line 26 previously recites “an assembly”. It is unclear which assembly is referred to by the term “The assembly” in claim 17, line 1.
In regards to claim 20, line 2 recites “the cuff”. Claim 20 depends upon claim 18, which depends upon claim 14, which depends upon claim 12, which depends upon claim 9. Claim 9, line 6 previously recites “a tracheal cuff” and line 22 recites “a distal inflatable lobar cuff”. It is unclear which cuff is referred to in claim 20, line 2.
In regards to claim 20, line 2 recites “selective delivery”. Claim 20 depends upon claim 18, which depends upon claim 14, which depends upon claim 12, which depends upon claim 9. Claim 9, line 28 previously recites “delivery”. It is unclear whether the two recitations are the same or different.
In regards to claim 20, line 2 recites “ventilation”. Claim 20 depends upon claim 18, which depends upon claim 14, which depends upon claim 12, which depends upon claim 9. Claim 9, line 18 previously recites “mechanical ventilation” and line 31 previously recites “simultaneous ventilation”. It is unclear whether “ventilation” is the same or different from “mechanical ventilation” or “simultaneous ventilation”.
In regards to claim 22, line 3 recites “an isolated lobe”. Claim 22, line 2 previously recites “a lobe”. It is unclear whether the two recitations are the same or different. Claims 23-26 and 29-30 are rejected by virtue of being dependent upon claim 22.
In regards to claim 22, line 3 recites “the device of claim 9”. Claim 9, line 1 recites “A respiratory apparatus assembly”. Thus, it is unclear whether claim 22, line 3 should instead recite “the respiratory apparatus assembly of claim 9”. Claims 23-26 and 29-30 are rejected by virtue of being dependent upon claim 22.
In regards to claim 22, lines 4-5 recite “the lung lobe”. First, there is insufficient antecedent basis for this limitation in the claim. Second, claim 22, line 2 previously recites “a lobe” and line 3 previously recites “an isolated lobe”. It is unclear whether “the lung lobe” is the same or different from “a lobe” or “an isolated lobe”. Claims 23-26 and 29-30 are rejected by virtue of being dependent upon claim 22.
In regards to claim 23, line 2 recites “therapeutics”. Claim 23 depends upon claim 22. Claim 22, line 1 previously recites “the drugs and biologics”. It is unclear whether the two recitations are the same or different.
In regards to claim 23, line 2 recites “the engaged lobar cuff”. First, there is insufficient antecedent basis for this limitation in the claim. Second, claim 23 depends upon claim 22. Claim 22, line 2 previously recites “a lobar tube cuff”. It is unclear whether the two recitations are the same or different.
In regards to claim 25, line 2 recites “the tracheal lumen channel”. First, there is insufficient antecedent basis for this limitation in the claim. Second, claim 25 depends upon claim 22, which depends upon claim 9. Claim 9, line 3 recites “a primary lumen”. It is unclear whether the two recitations are the same or different.
In regards to claim 26, lines 1-2 recite “therapeutic agents”. Claim 26 depends upon claim 22. Claim 22, line 1 previously recites “the drugs and biologics”. It is unclear whether the two recitations are the same or different.
In regards to claim 29, lines 1-2 recite “lobar delivery”. Claim 29 depends upon claim 22, which depends upon claim 9. Claim 9, line 28 previously recites “delivery”. It is unclear whether the two recitations are the same or different.
In regards to claim 30, lines 1-2 recite “selective delivery”. Claim 30 depends upon claim 22, which depends upon claim 9. Claim 9, line 28 previously recites “delivery”. It is unclear whether the two recitations are the same or different.
In regards to claim 30, line 4 recites “normal ventilation”. Claim 30 depends upon claim 22, which depends upon claim 9. Claim 9, line 18 previously recites “mechanical ventilation” and line 31 previously recites “simultaneous ventilation”. It is unclear whether “normal ventilation” is the same or different from “mechanical ventilation” or “simultaneous ventilation”.
Allowable Subject Matter
Claims 1, 9-20, 22-26, and 29-30 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action.
In regards to independent claim 1, the prior art of record does not disclose or render obvious before the effective filing date of the claimed invention the combination of a respiratory apparatus assembly, as claimed, specifically including the second connector comprises a removable cover that when removed provides access to the secondary channel or lumen, wherein the cover contains two entry ports with silicon valves and caps, The valves prevent leak during instrumentation and the cap provides seal necessary for mechanical ventilation.
Maracaja (US 2018/0272089) teaches a respiratory apparatus assembly (Figure 22) comprising: an endotracheal tube device comprising: an expandable secondary channel or lumen (of 2205), and a second connector (2209).
However, Maracaja does not teach the second connector comprises a removable cover that when removed provides access to the secondary channel or lumen, wherein the cover contains two entry ports with silicon valves and caps, The valves prevent leak during instrumentation and the cap provides seal necessary for mechanical ventilation.
Thus, independent claim 1 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b), set forth in this Office action.
In regards to independent claim 9, the prior art of record does not disclose or render obvious before the effective filing date of the claimed invention the combination of a respiratory apparatus assembly, as claimed, specifically including the second connector comprises a removable cover that when removed provides access to the secondary lumen, wherein the cover contains two entry ports with silicon valves and caps, the valves configured to prevent leak during instrumentation and the cap configured to provide a seal necessary for mechanical ventilation.
Maracaja teaches a respiratory apparatus assembly (Figure 22) comprising: an endotracheal tube comprising: an expandable secondary lumen (of 2205), and a second connector (2209).
However, Maracaja does not teach the second connector comprises a removable cover that when removed provides access to the secondary lumen, wherein the cover contains two entry ports with silicon valves and caps, the valves configured to prevent leak during instrumentation and the cap configured to provide a seal necessary for mechanical ventilation.
Thus, independent claim 9 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b), set forth in this Office action. Dependent claims 10-20, 22-26, and 29-30 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b), set forth in this Office action, by virtue of being dependent upon independent claim 9.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHEFALI D PATEL whose telephone number is (571)270-3645. The examiner can normally be reached Monday-Friday 8:30am-4:30pm EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin C Sirmons can be reached at (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SHEFALI D PATEL/Primary Examiner, Art Unit 3783